Biomedical Textiles Market

Biomedical textiles market was worth USD 15.2 billion in 2022 and is expected to be worth USD 20.7 billion by 2027, growing at a 6.3% CAGR during the forecast period. Biomedical textiles are fibrous structures designed for use in specific biological environments. The fibers used in these textiles are required to possess antimicrobial, non-allergic, and non-carcinogenic properties. They are produced using the weaving, non-weaving, and knitting technologies. The applications of biomedical textiles considered in this report are non-implantable, surgical sutures, implantable, and extracorporeal devices. The non-implantable applications of biomedical textiles include gauze, adhesive, cohesive, elastic tubular, and triangular bandages; whereas the implantable applications of biomedical textiles include soft tissue implants, hard tissue implants, dental prostheses, and vascular devices.

The Biomedical textiles market has been segmented on the basis of fiber, fabric, application, and region. On the basis of fiber, the market has been segmented into non-biodegradable (Polypropylene and Polyethylene, Cotton, Viscose, Polyester, Polyamide and others (Polyurethene, Polytetrafluoroethylene)), and biodegradable (Collagen, Chitin, PolyLactic Acid, PolyGlycolic Acid and others) fibers. On the basis of fabric, the market has been segmented into non-woven, woven, and others (Knitted, Braided and Hollow). On the basis of application, the market has been segmented into Non-implantable, Surgical Sutures, and others (Implantable and Extracorporeal Devices).

To know about the assumptions considered for the study download the pdf brochure

Royal DSM (Netherlands), Covidien (Ireland), Integra LifeSciences (US), Johnson & Johnson (US), Smith & Nephew (UK), Medline Industries (US), B. Braun Melsungen (Germany), and Cardinal Health (US) are the key players operating in the biomedical textiles market. These key players offer a wide range of biomedical textiles which strengthens their positions in the market. These players adopted product developments and expansions strategies, among others to cater the growing demand for biomedical textiles.

Royal DSM N.V., the key global science-based company is a major player in the biomedical textiles market. The company operates through four business segments, namely, Nutrition, Materials, Innovative Center, and Corporate Activities. It offers various types of food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy, and bio-based materials. It offers its biomedical textile products through its medical subsegment. The company has subsidiaries in five regions and business presence across 19 countries.

Medtronic plc offers biomedical textiles through its subsidiary, Covidien, and develops, manufactures, and distributes healthcare products. In 2015, Covidien was acquired by Medtronic (Ireland). Medtronic operates through its four business segments—Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. The company offers biomedical textiles under its Cardiac and Vascular Group and Medical Surgical business segments. Medtronic has presence in the Middle East, Europe, Asia Pacific, and the Americas and has 89 manufacturing facilities across the globe. Its subsidiaries include Covidien, Inc. (US), Tyco Healthcare (HKSAR), Ltd. (China), Tyco Healthcare Pte, Ltd. (Taiwan), Tyco Healthcare, Ltd. (Thailand), Covidien Vision Group (Japan), VNUS Medical Technologies, Inc. (US), Valleylab, Inc. (US), and Power Medical Interventions, Inc. (US).

Integra LifeSciences offers biomedical textiles through its subsidiary, Derman Sciences, Inc. Derma Sciences, Inc. is a medical technology developing company that majorly focuses on wound care. The company operates its business through two segments, namely, Codman Specialty Surgicals, and Total Tissue Technologies. Through the Codman Specialty Surgicals segment, the company offers both, novel and otherwise differentiated dressings, bandages, and skin substitutes designed to promote wound covering and protection, wound closure, and wound healing. Its Traditional Wound Care segment offers gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages, and other compression devices. In 2017, the company was acquired by Integra LifeSciences Corporation (US). Integra LifeSciences Corporation provides orthopedics and tissue technologies. Derma Sciences has manufacturing facilities in Toronto (Canada) and Nantong (China). Its major subsidiaries include Sunshine Products, Inc. (US), Derma Sciences Canada, Inc., (Canada), Derma First Aid Products, Inc. (US), MedEfficiency, Inc. (US), and Derma Sciences Europe, Ltd. (UK).

Related Reports:

Biomedical Textiles Market by Fiber Type (Non-Biodegradable, Biodegradable), Fabric Type (Non-Woven, Woven), Application (Non-Implantable, Surgical Sutures), and Region (North America, Europe, APAC, MEA, South America) - Global Forecast to 2027

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]